Skip to content

Very prideful about Prometheus

So Prometheus Biosciences. Takeover by Merck at $200 a share. Announced Sunday, Friday’s close was $114.

In my current little experiment I – while tooling around over a beer on Sunday night – said that at market open not everyone would have updated their prices. So, try buying right at 4 am.

Lo, and someone was able to buy RXDX at $130. And sell at $191 within the minute.

True, so far as can be seen it was one person globally. But a $10.5k outlay brought a $6.5 k profit in under a minute at pretty much zero risk. And it’s reasonably clear that it wasn’t my article which found that opportunity either (because it was obviously not me). But I did spot it, did get it written up and did publish ahead of time.

Most prideful.

Now, the other 49 ideas for this week then……

7 thoughts on “Very prideful about Prometheus”

  1. But I did spot it, did get it written up and did publish ahead of time.

    Were you not in a position to take advantage then? Because if I had the capacity to spot opportunities like that I would position myself (and bollocks to the journalism).

Leave a Reply

Your email address will not be published. Required fields are marked *